ThinkSabio

$ARQT

$24.70▲ +0.9% YTD

10 SEC 13D/G filings tracked · Last updated Oct 9, 2026

Filing History
News
ARQT ▲ +0.9% - Arcutis Biotherapeutics, Inc.
CP $24.70▲ +0.9%Oct 9, 2026 · ThinkSabio Blog

$ARQT some vol pm ARQT Arcutis Presents ZORYVE® (roflumilast) Data and Real-World Topical Corticosteroid Research at EADV and Fall Clinical…

News
ARQT ▲ +1.8% - Arcutis Biotherapeutics, Inc.
CP $24.94▲ +1.8%Oct 9, 2026 · ThinkSabio Blog

$ARQT - Arcutis Presents ZORYVE® (roflumilast) Data and Real-World Topical Corticosteroid Research at EADV and Fall Clinical…

News
ARQT ▲ +0.4% - Arcutis Biotherapeutics, Inc.
CP $25.25▲ +0.4%Oct 6, 2026 · ThinkSabio Blog

$ARQT - Arcutis’ ZORYVE® (roflumilast) Wins 2026 Marie Claire Beauty Award…

SEC 13D/G
ARQT - Arcutis Biotherapeutics, Inc. - SEC Filing Update (05-OCT-2026) | ThinkSabio - Stocks Simplified
$24.89▼ -14.11%Oct 5, 2026 · ThinkSabio Blog

$ARQT SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #ARQT Arcutis Biotherapeutics, Inc. : $24.89 Sector: Healthcare…

News
ARQT ▼ -0.6% - Arcutis Biotherapeutics, Inc.
CP $25.16▲ -0.6%Oct 2, 2026 · ThinkSabio Blog

$ARQT - Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)…

News
ARQT ▲ +0.2% - Arcutis Biotherapeutics, Inc.
CP $27.41▲ +0.2%Sep 29, 2026 · ThinkSabio Blog

$ARQT - Simone Biles Partners with Arcutis to Launch the Skin to Believe In Campaign, Raising Awareness of Seborrheic Dermatitis and Eczema, and Inspi…

News
ARQT ▲ +1.0% - Arcutis Biotherapeutics, Inc.
CP $23.90▲ +1.0%Sep 4, 2026 · ThinkSabio Blog

$ARQT - Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)…

News
ARQT ▲ +0.7% - Arcutis Biotherapeutics, Inc.
CP $23.85▲ +0.7%Sep 2, 2026 · ThinkSabio Blog

$ARQT - Arcutis Management to Present at the Morgan Stanley 24th Annual Global Healthcare Conference…

SEC 13D/G
ARQT - Arcutis Biotherapeutics, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks Simplified
$26.51▼ -8.52%Aug 14, 2026 · ThinkSabio Blog

$ARQT SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #ARQT Arcutis Biotherapeutics, Inc. : $26.51 Sector: Healthcare…

SEC 13D/G
ARQT - Arcutis Biotherapeutics, Inc. - SEC Filing Update (07-AUG-2026) | ThinkSabio - Stocks Simplified
$27.35▼ -5.62%Aug 7, 2026 · ThinkSabio Blog

$ARQT SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #ARQT Arcutis Biotherapeutics, Inc. : $27.35 Sector: Healthcare…